UCSD Health assessing antiviral treatment for COVID-19
UC San Francisco, UC Irvine Health, and UC Davis Health are also participating in the trials. The trial is projected to run until April 1, 2023 and involve 440 participants.
UCSD Health assessing antiviral treatment for COVID-19
UC San Francisco, UC Irvine Health, and UC Davis Health are also participating in the trials. The trial is projected to run until April 1, 2023 and involve 440 participants.